Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations.

Daga PR, Duan J, Doerksen RJ.

Protein Sci. 2010 Apr;19(4):796-807. doi: 10.1002/pro.359.

2.
3.

Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.

Li J, Du Y, Liu X, Shen QC, Huang AL, Zheng MY, Luo XM, Jiang HL.

Acta Pharmacol Sin. 2013 Feb;34(2):319-28. doi: 10.1038/aps.2012.146. Epub 2012 Dec 3.

4.

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

Angus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, Brosgart C, Colledge D, Edwards R, Ayres A, Bartholomeusz A, Locarnini S.

Gastroenterology. 2003 Aug;125(2):292-7.

PMID:
12891527
5.

Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations.

Bartholomeusz A, Tehan BG, Chalmers DK.

Antivir Ther. 2004 Apr;9(2):149-60. Review.

PMID:
15134177
6.

In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.

Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V.

Antivir Ther. 2004 Jun;9(3):353-63.

PMID:
15259898
7.
8.

Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.

Iyer RP, Jin Y, Roland A, Morrey JD, Mounir S, Korba B.

Antimicrob Agents Chemother. 2004 Jun;48(6):2199-205.

9.

The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.

Amini-Bavil-Olyaee S, Herbers U, Sheldon J, Luedde T, Trautwein C, Tacke F.

Hepatology. 2009 Apr;49(4):1158-65. doi: 10.1002/hep.22790.

PMID:
19263474
10.

Impact of rtI233V mutation in hepatitis B virus polymerase protein and adefovir efficacy: Homology modeling and molecular docking studies.

Ismail AM, Sharma OP, Kumar MS, Kannangai R, Abraham P.

Bioinformation. 2013;9(3):121-5. doi: 10.6026/97320630009121. Epub 2013 Feb 6.

11.

Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.

Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, Rossau R.

J Clin Microbiol. 2000 Feb;38(2):702-7.

12.
13.

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine.

Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ.

Hepatology. 1996 Sep;24(3):711-3.

PMID:
8781347
14.

[Study on the relations between hepatitis B virus large surface protein (LHBs) and HBV YMDD mutation].

Wang LJ, Sun Y, Fu HP.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Feb;24(1):48-9. Chinese.

PMID:
20848850
15.

Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.

Sheldon J, Camino N, Rodés B, Bartholomeusz A, Kuiper M, Tacke F, Núñez M, Mauss S, Lutz T, Klausen G, Locarnini S, Soriano V.

Antivir Ther. 2005;10(6):727-34.

PMID:
16218172
16.

The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro.

Warner N, Locarnini S, Kuiper M, Bartholomeusz A, Ayres A, Yuen L, Shaw T.

Antimicrob Agents Chemother. 2007 Jul;51(7):2285-92. Epub 2007 Apr 16.

17.

Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.

Gutfreund KS, Williams M, George R, Bain VG, Ma MM, Yoshida EM, Villeneuve JP, Fischer KP, Tyrrel DL.

J Hepatol. 2000 Sep;33(3):469-75.

PMID:
11020004
18.

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.

Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD.

Hepatology. 1998 Jun;27(6):1670-7.

PMID:
9620341
19.
20.

Supplemental Content

Support Center